Inventor · disambiguated record
Gregory Dietsch
Also filed as: DIETSCH GREGORY · DIETSCH GREGORY N
11 granted patents·17 pending applications·38 citations·filing 2001–2024
88Inventor score
Files withSUDO BIOSCIENCES LTD9VENTIRX PHARMACEUTICALS INC5ABBVIE INC3HOWBERT JAMES JEFFRY3MAVUPHARMA INC3
Top patents by PatentIndex Score
28 records- 0192US11613548B2Substituted pyridines, pyridazines, pyrimidines, and 1,2,4-triazines as TYK2 inhibitorsSUDO BIOSCIENCES LTD·Filed 2022·Granted Mar 28, 2023·3 cites·21 claims
- 0289US12103937B2Substituted pyridines and pyridazines as TYK2 inhibitorsSUDO BIOSCIENCES LTD·Filed 2023·Granted Oct 1, 2024·1 cites·21 claims
- 0389US12084458B2Substituted pyridines, pyridazines, and pyrimidines as TYK2 inhibitorsSUDO BIOSCIENCES LTD·Filed 2023·Granted Sep 10, 2024·1 cites·21 claims
- 0488US12122785B2Substituted pyridines, pyridazines, pyrimidines, and 1,2,4-triazines as TYK2 inhibitorsSUDO BIOSCIENCES LTD·Filed 2023·Granted Oct 22, 2024·1 cites·20 claims
- 0586US8242106B2Toll-like receptor agonist formulations and their useHOWBERT J JEFFRY·Filed 2009·Granted Aug 14, 2012·10 cites·21 claims
- 0684US8691809B2Substituted benzoazepines as toll-like receptor modulatorsHOWBERT JAMES JEFFRY·Filed 2010·Granted Apr 8, 2014·8 cites·17 claims
- 0781US8524702B2Substituted benzoazepines as toll-like receptor modulatorsHOWBERT JAMES JEFFRY·Filed 2010·Granted Sep 3, 2013·6 cites·20 claims
- 0881US2024383916A1Substituted pyridines, pyridazines, and pyrimidines as tyk2 inhibitorsSUDO BIOSCIENCES LTD·Filed 2024·Application pending·0 cites
- 0981US2024391934A1Substituted pyridines and pyridazines as tyk2 inhibitorsSUDO BIOSCIENCES LTD·Filed 2024·Application pending·0 cites
- 1078US2025011335A1Substituted pyridines, pyridazines, pyrimidines, and 1,2,4-triazines as tyk2 inhibitorsSUDO BIOSCIENCES LTD·Filed 2024·Application pending·0 cites
- 1177US9655904B2Substituted benzoazepines as toll-like receptor modulatorsVENTIRX PHARMACEUTICALS INC·Filed 2015·Granted May 23, 2017·2 cites·8 claims
- 1277US9126940B2Substituted benzoazepines as toll-like receptor modulatorsVENTIRX PHARMACEUTICALS INC·Filed 2014·Granted Sep 8, 2015·3 cites·15 claims
- 1374US9242964B2Substituted benzoazepines as toll-like receptor modulatorsVENTIRX PHARMACEUTICALS INC·Filed 2013·Granted Jan 26, 2016·2 cites·20 claims
- 1469US9216192B2Toll-like receptor agonist formulations and their useHOWBERT J JEFFRY·Filed 2012·Granted Dec 22, 2015·1 cites·15 claims
- 1567US2023183239A1Ectonucleotide pyrophosphatase-phosphodiesterase 1 (enpp-1) inhibitors and uses thereofABBVIE INC·Filed 2022·Application pending·0 cites
- 1655US2020291024A1Ectonucleotide pyrophosphatase-phosphodiesterase 1 (enpp-1) inhibitors and uses thereofABBVIE INC·Filed 2018·Application pending·0 cites
- 1755US2024189309A1Tyk2 inhibitors and uses thereofSUDO BIOSCIENCES LTD·Filed 2022·Application pending·0 cites
- 1853US2024124440A1Tyk2 inhibitors and uses thereofSUDO BIOSCIENCES LTD·Filed 2021·Application pending·0 cites
- 1946US2016331758A1Toll-like receptor agonist formulations and their useVENTIRX PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 2046US2016137608A1Substituted benzoazepines as toll-like receptor modulatorsHOWBERT JAMES JEFFRY·Filed 2015·Application pending·0 cites
- 2145US2019282703A1Ectonucleotide pyrophosphatase-phosphodiesterase (enpp) conjugates and uses thereofMAVUPHARMA INC·Filed 2018·Application pending·0 cites
- 2245US2020085782A1Compositions and methods of enhancing or augmenting type i ifn productionMAVUPHARMA INC·Filed 2017·Application pending·0 cites
- 2343US2021023234A1Ectonucleotide pyrophosphate-phosphodiesterase (enpp) conjugates and uses thereofABBVIE INC·Filed 2019·Application pending·0 cites
- 2442US2012219615A1Therapeutic Use of a TLR Agonist and Combination TherapyHERSHBERG ROBERT·Filed 2011·Application pending·0 cites
- 2541US2018303845A1Use of tlr8 agonists to treat cancerVENTIRX PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 2640US2020085828A1Phosphodiesterase inhibitors and methods of microbial treatmentMAVUPHARMA INC·Filed 2017·Application pending·0 cites
- 2739US2003215439A1Therapeutic uses of PAF-AH products in diabetesFiled 2003·Application pending·0 cites
- 2838US2002102231A1Therapeutic uses of PAF-AH products in diabetesICOS CORP·Filed 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Gregory Dietsch files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →